Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 9, No 3 (2013) STATINS AND RISK OF INFECTIOUS DISEASES Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
"... , and pneumonia particularly. Results of the large studies on statin influence on infectious disease are presented. ..."
 
Vol 6, No 4 (2010) HYPOANDROGEN CONDITION AND CARDIOVASCULAR DISEASES: ACTUAL QUESTIONS OF COMORBIDITY IN CLINICAL PRACTICE Abstract  similar documents
G. G. Sharvadze, D. G. Kurbatov, E. A. Poddubskaya, M. N. Mamedov
"... The correlation of age-dependent reduction in sex hormones level and changes of cardiovascular ..."
 
Vol 5, No 3 (2009) RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES Abstract  similar documents
E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov
"... to provide high level of compliance in patients with cardiovascular diseases. ..."
 
Vol 6, No 1 (2010) THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
"... Data of the evidence based medicine about bisoprolol treatment of patients with cardiovascular ..."
 
Vol 7, No 6 (2011) DETERMINANTS OF PREVENTIVE BEHAVIOR REGARDING CARDIOVASCULAR DISEASES AND RISK FACTORS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
D. Yu. Platonov, T. A. Kostjuk, A. I. Brandt, O. V. Tsygankova
"... logistic regression. Results. Awareness of the cardiovascular diseases (CVD) and its prevention (odds ratio ..."
 
Vol 11, No 6 (2015) Alcohol consumption in patients with cardiovascular diseases (results of the survey of cardiac patients in outpatient practice) Abstract  similar documents
O. D. Ostroumova, I. E. Nikolaeva, S. Ya. Eregin, I. V. Pokrovskaya, K. A. Ishchenko
"... in outpatients with cardiovascular diseases allows identifying a subgroup of patients (more in men) who have ..."
 
Vol 4, No 4 (2008) BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST Abstract  similar documents
L. N. Malaj
"... Usage of β-blockers (BB) for treatment of patients with cardiovascular diseases is discussed ..."
 
Vol 18, No 1 (2022) Cardiovascular Effects of Metformin Abstract  similar documents
B. T. Kurmanbekova, A. M. Noruizbaeva
"... , progression and mortality from cardiovascular diseases (CVD). The world communities are faced ..."
 
Vol 14, No 2 (2018) DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT Abstract  similar documents
N. В. Perepech, A. V. Tregubov
"... for primary and secondary prevention of cardiovascular diseases. 276 questionnaires filled out by 185 ..."
 
Vol 5, No 4 (2009) COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS Abstract  PDF (Eng)  similar documents
N. A. Karoli, A. P. Rebrov
"... Aim. To study prevalence and features of cardiovascular diseases (arterial hypertension, ischemic ..."
 
Vol 10, No 1 (2014) ARTERIAL STIFFNESS AND CHRONIC KIDNEY DISEASE: CAUSES AND CONSEQUENCES Abstract  similar documents
J. D. Kobalava, Yu. V. Kotovskaya, S. V. Villevalde, A. E. Soloveva, I. M. Amirbegishvili
"... Chronic kidney disease (CKD) is associated with increased cardiovascular risk. CKD ..."
 
Vol 16, No 4 (2020) Epicardial Adipose Tissue as a New Target of Therapeutic Interventions Abstract  similar documents
M. A. Druzhilov, T. Y. Kuznetsova
"... to evaluate its effectiveness in various cardiovascular diseases. ..."
 
Vol 16, No 4 (2020) Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues Abstract  similar documents
M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova
"... in a significant proportion of patients with atherosclerotic cardiovascular diseases (ACVD) is impossible ..."
 
Vol 10, No 1 (2014) MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) Abstract  PDF (Eng)  similar documents
A. M. Kalinina
"... primary prevention of atherosclerosis-mediated cardiovascular diseases. Primary medical prevention has ..."
 
Vol 12, No 3 (2016) REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION" Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, M. M. Loukianov, N. P. Kutishenko
"... of various cardiovascular diseases (CVD) were among participants of the meeting. The importance of modern ..."
 
Vol 12, No 5 (2016) The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies Abstract  similar documents
E. K. Butina, E. V. Bochkareva
"... Measures for the prevention of cardiovascular diseases (CVD) are more effective ..."
 
Vol 5, No 2 (2009) DOCTOR INERTNESS AS A FACTOR DISTURBING EFFECTIVE TREATMENT OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. V. Minakov, R. A. Khokhlov, G. I. Furmenko, N. M. Akhmedzhanov
"... which treat and follow-up patients with cardiovascular diseases (CVD). Material and methods ..."
 
Vol 5, No 3 (2009) ARTERIAL HYPERTENSION IN PATIENTS WITH RHEUMATOID ARTHRITIS Abstract  similar documents
N. M. Nikitina, A. P. Rebrov
 
Vol 13, No 1 (2017) THE LINK BETWEEN VITAMIN В12 DEFICIENCY, RISK OF CARDIOVASCULAR DISEASES AND AGING PROCESS Abstract  similar documents
O. M. Drapkina, R. N. Shepel
"... diseases. Usually internists consider that vitamin В12 deficiency is associated with disturbances ..."
 
Vol 13, No 6 (2017) SMOKING AS A RISK FACTOR OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 1. Smoking Prevalence and Impact on Prognosis Abstract  similar documents
O. D. Ostroumova, A. A. Izvekov, N. Yu. Voevodina
"... heart disease (IHD); cerebral circulation disorders; lower respiratory tract infection; chronic ..."
 
Vol 14, No 1 (2018) SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking Abstract  similar documents
O. D. Ostroumova, I. I. Kopchjonov, T. F. Guseva
"... who continue to smoke. Smoking cessation is the most cost-effective strategy of cardiovascular disease ..."
 
Vol 7, No 4 (2011) METHODS OF ASSISTANCE FOR SMOKING CESSATION IN INTERNATIONAL CLINICAL RECOMMENDATIONS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE Abstract  similar documents
M. S. Berezhnova
"... of cardiovascular disease. There are a lot of approaches to drop smoking including innovative pharmacotherapy ..."
 
Vol 6, No 5 (2010) PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE Abstract  similar documents
M. N. Mamedov, G. G. Sharvadze, E. A. Poddubsky, A. K. Ausheva
"... of ED in the majority of men (about 80% of patients) is cardiovascular diseases (atherosclerosis ..."
 
Vol 10, No 1 (2014) MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT Abstract  similar documents
E. I. Trisvetova
"... Progression of cardiovascular disease is often caused by a deficiency of magnesium in the human ..."
 
Vol 10, No 4 (2014) MODERN PRINCIPLES OF QUALITY ASSESSMENT OF CARDIOVASCULAR DISEASES TREATMENT Abstract  similar documents
A. Yu. Suvorov, S. Yu. Martsevich
"... The most common ways of assessment of cardiovascular diseases treatment abroad, approaches ..."
 
Vol 1, No 1 (2005) ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES Abstract  similar documents
Y. A. Karpov
"... of the role of ACE inhibitors in treatment of patients with stable form of ischemic heart disease without ..."
 
Vol 8, No 4 (2012) UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina
"... cardiovascular diseases is one of the priorities of modern medicine. This therapy usually consists of several ..."
 
Vol 8, No 5 (2012) ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? Abstract  similar documents
S. A. Boldueva, I. A. Leonova
"... and the main indications are discussed. ASA use for primary cardiovascular diseases prevention and its possible ..."
 
Vol 5, No 1 (2009) CARDIOLOGICAL MANAGEMENT OF PREGNANT WOMEN IN THE UDMURT REPUBLIC Abstract  similar documents
I. R. Gaisin, R. M. Valeeva, L. V. Shilina, N. Yu. Chernisheva, N. I. Maksimov
"... Aim. To assess the efficacy of specialized management of pregnant women with cardiovascular ..."
 
Vol 14, No 5 (2018) Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study Abstract  similar documents
I. L. Polshakova, S. V. Povetkin
"... data, the type and duration of AF, cardiovascular diseases (CVD), concomitant noncardiac pathology ..."
 
Vol 15, No 4 (2019) Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare Abstract  similar documents
O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel
"... of cardiovascular complications for primary prevention in a wide population are presented. The question of the ratio ..."
 
Vol 17, No 5 (2021) A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases Abstract  PDF (Eng)  similar documents
Yu. V. Bulaeva, E. A. Naumova, O. N. Semenova, T. V. Kanaeva, K. A. Popov, А. R. Tyapayeva
"... . 120 patients admitted to hospital with cardiovascular diseases were included in the study. Patients ..."
 
Vol 12, No 4 (2016) Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk Abstract  similar documents
O. M. Drapkina, O. N. Korneeva
"... for a number of cardiovascular diseases (CVD), is considered. The high prevalence of cardiovascular risk ..."
 
Vol 13, No 3 (2017) BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL Abstract  similar documents
I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov
"... kidney diseases (CKD) and the development of cardiovascular complications. Immune and non-immune ..."
 
Vol 11, No 2 (2015) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? Abstract  similar documents
S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov
"... with cardiovascular diseases and concomitant chronic liver diseases. Material and methods. Сross-sectional ..."
 
Vol 11, No 5 (2015) Excess winter cardiovascular morbidity in Ivanovo Region in 2009-2013 years Abstract  similar documents
A. V. Kontsevaya, J. A. Balanova, M. M. Loukianov, M. B. Khudyakov, O. A. Belova, S. V. Romanchuk
"... . The incidence of cardiovascular diseases (CVDs) was determined according to the data from the medical ..."
 
Vol 15, No 2 (2019) Detectability of Subclinical Hypothyroidism and Thyroid Stimulating Hormone Levels Associated with Cardiovascular Diseases in Patients of North-West Region Hospital Abstract  similar documents
A. R. Volkova, O. D. Dygun, O. N. Zhdanova, B. G. Lukichev, L. A. Belyakova, E. M. Sereda
"... with cardiovascular diseases (CVD) is an important clinical task. Aim. To study the detectability of subclinical ..."
 
Vol 15, No 3 (2019) Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases Abstract  similar documents
E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina
"... with the prevalence and mortality from cardiovascular diseases (CVD). The presence of BAC on mammograms is associated ..."
 
Vol 3, No 1 (2007) THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION Abstract  similar documents
D. B. Nebieridze, A. S. Safaryan
"... demonstrate the efficacy of ACE inhibitors in slowing down of disease progression related to atherosclerosis ..."
 
Vol 10, No 4 (2014) DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF “ATRIAL FIBRILLATION” IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA) Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... of CardioVAScular diseAses (RECVASA). 530 of 3690 (14.4%) patients had the "atrial fibrillation" diagnosis ..."
 
Vol 15, No 2 (2019) Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics Abstract  similar documents
G. P. Arutyunov, S. A. Boytsov, M. I. Voyevoda, V. S. Gurevich, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, I. V. Sergiyenko, M. V. Shestakova, A. S. Aliyeva, N. M. Akhmedzhanov, M. G. Bubnova, А. S. Galyavich, I. G. Gordeyev, M. V. Ezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Ya. A. Orlova, A. V. Panov, S. A. Sayganov, V. V. Skibitskiy, E. I. Tarlovskaya, S. A. Urazgildeyeva, Yu. Sh. Khalimov
"... high and extremely high cardiovascular risk. The indication for the pharmacological treatment to reduce ..."
 
Vol 18, No 5 (2022) Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19 Abstract  similar documents
A. A. Smirnov, M. M. Loukianov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Maltseva, E. N. Belova, V. G. Klyashtorniy, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina
"... diseases (CVD) and long-term outcomes in post-COVID-19 patients with cardiovascular multimorbidity (CVMM ..."
 
Vol 17, No 4 (2021) Assessment of Arterial Stiffness Using the Cardio-Ankle Vascular Index – What We Know and What We Strive for Abstract  similar documents
A. N. Sumin, A. V. Shcheglova
"... for assessing cardiovascular diseases and risk factors, which has allowed for the expansion and deepening ..."
 
Vol 12, No 2 (2016) PLEIOTROPIC EFFECTS OF VITAMIN D Abstract  similar documents
O. M. Drapkina, R. N. Shepel
"... of pathogenetic ways to implement these effects  is presented. Relation of vitamin D with cardiovascular diseases ..."
 
Vol 8, No 6 (2012) ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK Abstract  similar documents
M. N. Kovrigina, M. N. Mamedov
"... Aim. To assess the risk of diabetes mellitus type 2 (DM2) in patients with various cardiovascular ..."
 
Vol 5, No 4 (2009) TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS Abstract  similar documents
L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky
"... down progression of cardiovascular diseases and reduce risk of mortality and life threatening ..."
 
Vol 7, No 1 (2011) SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW Abstract  similar documents
S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina
"... A role of angiotensin-converting enzyme (ACE) inhibitors in cardiovascular diseases treatment ..."
 
Vol 6, No 4 (2010) ECONOMIC EFFICIENCY OF THE IMPLEMENTATION OF THE PROGRAM OF CARDIOVASCULAR DISEASES MULTIFACTORIAL PREVENTION IN THE ORGANIZED COLLECTIVE OF TECHNICAL RESEARCH INSTITUTE Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina, S. V. Belonosova, J. M. Pozdnjakov, M. B. Khudyakov
"... consultation. Costs associated with cardiovascular diseases and risk factors (medical care consumption ..."
 
Vol 10, No 2 (2014) HYPERURICEMIA AND ITS CORRELATES IN THE RUSSIAN POPULATION (RESULTS OF ESSE-RF EPIDEMIOLOGICAL STUDY) Abstract  similar documents
S. A. Shalnova, A. D. Deev, G. V. Artamonov, D. V. Duplyakov, A. Yu. Efanov, Yu. V. Zhernakova, A. O. Konradi, R. A. Libis, G. A. Muromtseva, S. V. Nedogoda, E. V. Oschepkova, S. V. Romanchuk, O. P. Rotar, V. N. Titov, Z. A. Toguzova, I. A. Trubacheva, G. I. Furmenko, E. V. Shlyakhto, S. A. Boytsov
"... social and demographic characteristics as well as cardiovascular risk factors are revealed. ..."
 
Vol 11, No 3 (2015) PREVALENCE OF TYPE D PERSONALITY AND ITS ASSOCIATION WITH CARDIOVASCULAR DISEASES AND THEIR RISK FACTORS ACCORDING TO THE ESSE STUDY CONDUCTED IN KEMEROVO REGION Abstract  similar documents
A. N. Sumin, O. I. Raykh, E. V. Indukaeva, G. V. Artamonova
"... in the development and carrying out programs of primary and secondary prevention of cardiovascular diseases. ..."
 
Vol 15, No 5 (2019) Adverse Reactions of the Cardiovascular System when Taking Nonsteroidal Anti-inflammatory Drugs and Ways to Reduce Them Abstract  similar documents
N. V. Pyrikova, O. N. Antropova, I. V. Osipova
"... presents data on the mutual potential impact of cardiovascular diseases and musculoskeletal system ..."
 
Vol 15, No 6 (2019) Prospects for Blood Pressure Remote Monitoring in Hypertensive Patients in the Ryazan Region Abstract  similar documents
N. V. Aksenova, A. A. Nizov, O. N. Selyavina, E. I. Suchkova, E. V. Filippov
 
Vol 16, No 1 (2020) Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice Abstract  similar documents
M. M. Loukianov, A. V. Kontsevaya, A. O. Myrzamatova, M. B. Khudyakov, E. Y. Okshina, E. V. Kudryashov
"... of dapagliflozin in patients with a combination of cardiovascular disease (CVD) and type 2 diabetes in Russian ..."
 
Vol 16, No 2 (2020) Patients with Premature Cardiovascular Diseases in Ambulatory Practice: Demographic Characteristics, Risk Factors and Adherence to the Medical Therapy (Data of RECVASA Registry) Abstract  similar documents
E. Yu. Andreenkо, M. M. Loukianov, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, V. A. Dindikova, A. N. Makoveeva, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina
"... Aim. To evaluate the gender characteristics, educational level, cardiovascular diseases (CVD) risk ..."
 
Vol 9, No 5 (2013) LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY Abstract  similar documents
O. I. Afanasieva, S. N. Pokrovsky
 
Vol 9, No 6 (2013) FEATURES OF SEASONAL CARDIOVASCULAR MORTALITY IN WINTER IN RUSSIAN REGIONS WITH DIFFERENT CLIMATIC AND GEOGRAPHICAL CHARACTERISTICS Abstract  similar documents
S. A. Boytsov, M. M. Lukyanov, A. V. Kontsevaya, A. D. Deev, Yu. A. Balanova, A. V. Kapustina, V. G. Klyashtorny, M. B. Hudyakov
"... Aim. To study seasonal changes in cardiovascular mortality in winter in Arkhangelsk, Ivanovo ..."
 
Vol 10, No 3 (2014) OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE Abstract  similar documents
E. L. Trisvetova
"... Comorbidity of cardiovascular diseases reciprocally aggravates their course and induces the need ..."
 
Vol 11, No 5 (2015) The role of peptide hormones (adiponectin, leptin, insulin) in the pathogenesis of atherosclerosis Abstract  similar documents
S. A. Smetnev, A. N. Meshkov
"... Currently, cardiovascular diseases (CVD) remain the main problem in the world and in Russia ..."
 
Vol 3, No 1 (2007) DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE Abstract  similar documents
S. Y. Martsevich
"... on the risk of cardiovascular complications. The place of dihydropyridine calcium antagonists in modern ..."
 
Vol 8, No 1 (2012) COMPLIANCE TO LONG-TERM TREATMENT OF CARDIOLOGIC PATIENTS WITH MILD TO MODERATE DEPRESSION: INEFFECTIVENESS OF ANTIDEPRESSIVE THERAPY WITH PIRLINDOL IN RANDOMIZED STUDY Abstract  similar documents
E. V. Strokova, E. A. Naumova, J. G. Shvarts
"... -term treatment and quality of life in patients with cardiovascular diseases and mild to moderate ..."
 
Vol 8, No 1 (2012) PRIMARY PREVENTION OF DIABETES MELLITUS: CORRECTION OF EARLY DISORDERS OF GLUCOSE METABOLISM IN CARDIOLOGY PRACTICE Abstract  similar documents
M. N. Mamedov, E. A. Poddubskaya, M. N. Kovrigina, Z. O. Ugurchieva, R. T. Digigova
"... are an independent risk factor for cardiovascular disease. The possibilities of GMD prevention and early treatment ..."
 
Vol 8, No 5 (2012) HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... Aim. To study relationship between heart rate (HR) and traditional risk factors for cardiovascular ..."
 
Vol 14, No 2 (2018) ECONOMIC BURDEN OF CARDIOVASCULAR DISEASES IN THE RUSSIAN FEDERATION IN 2016 Abstract  PDF (Eng)  similar documents
A. N. Kontsevaya, O. M. Drapkina, Yu. A. Balanova, A. E. Imaeva, E. I. Suvorova, M. B. Khudyakov
"... Aim. To evaluate the economic burden of cardiovascular diseases (CVD) in the Russian Federation ..."
 
Vol 14, No 5 (2018) Metabolic Syndrome: Development of the Issue, Main Diagnostic Criteria Abstract  similar documents
Yu. N. Belenkov, E. V. Privalova, V. Y. Kaplunova, V. Y. Zektser, N. N. Vinogradova, I. S. Ilgisonis, G. A. Shakaryants, M. V. Kozhevnikova, A. S. Lishuta
"... Obesity is one of the leading and the most serious risk factors of cardiovascular diseases ..."
 
Vol 15, No 1 (2019) The Trends of Cardiovascular and Cancer Mortality in Russian Men and Women from 2000 to 2016 years Abstract  similar documents
S. A. Shalnova, O. M. Drapkina
"... coronary heart disease (CHD), cerebrovascular disease (CerVD), other CVD, and cancer, including prostate ..."
 
Vol 15, No 2 (2019) Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 1. Breast Arterial Calcification: Pathomorphology, Prevalence and Risk Factors Abstract  similar documents
E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina
"... with cardiovascular diseases (CVD). This allows it to be considered as a new marker of cardiovascular risk in women ..."
 
Vol 15, No 4 (2019) The Association of Smoking Status and Intensity of Smoking with Blood Lipid Spectrum in a Sample of Middle-Aged Men Abstract  similar documents
A. A. Alexandrov, V. B. Rozanov, M. B. Kotova, V. A. Dadaeva, E. I. Ivanova
 
Vol 15, No 5 (2019) The Concept of Early Vascular Aging Abstract  similar documents
N. V. Burko, I. V. Avdeeva, V. E. Oleynikov, S. A. Boytsov
"... the development of cardiovascular events in young people. This phenomenon is described as a syndrome of early ..."
 
Vol 17, No 6 (2021) Factors Determining the Three-Year Dynamics of Lipid Metabolism Indicators in Residents of a Large Industrial Region of Siberia Abstract  similar documents
D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, A. S. Agienko, O. V. Nakhratova, G. V. Artamonova, O. L. Barbarash
"... the state of health (presence of diseases, taking medications), socio-economic status (level of education ..."
 
Vol 17, No 6 (2021) Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy Abstract  similar documents
A. V. Nelidova, M. A. Livzan, N. A. Nikolaev, T. S. Krolevets
"... The association of non-alcoholic fatty liver disease (NAFLD) and cardiovascular risk is currently ..."
 
Vol 18, No 2 (2022) Hostility, Anger, Psycho-emotional Factors and Cardiovascular Disease Abstract  similar documents
G. F. Andreeva, V. M. Gorbunov
"... , hostility, anger and cardiovascular diseases. The first chapter describes the main historical stages ..."
 
Vol 18, No 4 (2022) Uric Acid as a Risk Factor for Cardiovascular Diseases Abstract  similar documents
A. S. Safaryan, A. S. Lishuta, D. V. Nebieridze
"... Recently, hyperuricemia and its association with cardiovascular disease have been receiving more ..."
 
Vol 18, No 4 (2022) Parameters of the Infrastructure of the Residential Area and Their Relationship with Cardiovascular Risk Factors Abstract  similar documents
T. A. Mulerova, T. F. Gaziev, E. D. Bazdyrev, E. V. Indukaeva, D. P. Tsygankova, O. V. Nakhratova, A. S. Agienko, G. V. Artamonova
"... in Kemerovo Oblast and their connection to cardiovascular disease risk factors. Subjects and methods ..."
 
Vol 18, No 5 (2022) Assessment of Drug Related Problems and Pharmacist Interventions in Inpatients with Cardiovascular Disease Abstract  PDF (Eng)  similar documents
S. M. Biradar, B. Kohima, V. Nayak, S. Nandikol, V. Warad, S. M. Byakod, B. S. Hunasagi, S. R. Awasthi
"... of medications with cardiovascular disease patients by using PCNE Classification to assess and report drug ..."
 
Vol 18, No 6 (2022) Natriuresis as a Way to Assess the Effectiveness of Diuretic Therapy for Acute Decompensated Heart Failure: Data from a Pilot Study Abstract  similar documents
K. V. Charaya, D. Yu. Shchekochikhin, S. N. Tarasenko, N. A. Ananicheva, S. A. Sovetova, T. V. Soboleva, O. N. Dikur, A. I. Borenstein, D. A. Andreev
 
Vol 18, No 1 (2022) The Impact of Combination Therapy with Rivaroxaban and Acetylsalicylic Acid in Patients with Coronary Heart Disease on the Achievement of the Target for Reducing Mortality from Cardiovascular Diseases of the Federal Project "Fight against Cardiovascular Diseases" Abstract  similar documents
M. V. Zhuravleva, A. V. Panov, A. R. Kuksenok
"... of the number of deaths due to cardiovascular disease (CVD), number of strokes and myocardial infarction (MI ..."
 
Vol 12, No 1 (2016) Effect of magnesium on the cardiovascular system in women Abstract  PDF (Eng)  similar documents
E. A. Ulubieva, A. G. Avtandilov
"... Recent scientific data on the influence of magnesium on the cardiovascular and reproductive system ..."
 
Vol 12, No 3 (2016) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? Abstract  PDF (Eng)  similar documents
S. N. Bel'diev
"... to use statins in patients with cardiovascular diseases and concomitant chronic liver diseases. Analysis ..."
 
Vol 13, No 1 (2017) SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION Abstract  similar documents
S. N. Bel'diev
"... Russian physicians often afraid to use statins in patients with high cardiovascular risk ..."
 
Vol 7, No 5 (2011) DIETARY FATTY ACIDS. EFFECTS ON THE RISK OF CARDIOVASCULAR DISEASES Abstract  similar documents
N. V. Perova, V. A. Metel'skaya, E. I. Sokolov, G. N. Shchukina, V. M. Fomina
"... fats on the development of cardiovascular diseases and acute complications due to atherothrombosis ..."
 
Vol 11, No 4 (2015) THE ATTITUDE TOWARDS TREATMENT OF CARDIOVASCULAR DISEASES: A SURVEY OF PATIENTS OF STATE OUTPATIENT CLINICS AND PRIVATE MEDICAL CENTERS Abstract  similar documents
O. N. Semenova, E. A. Naumova, Yu. G. Shvarts
"... Aim. To study the differences in views on treatment among patients with cardiovascular diseases ..."
 
Vol 16, No 2 (2020) Glomerular Filtration Rate, its Association with Risk Factors and Cardiovascular Diseases. The Results of the ESSE-RF-2 Study Abstract  similar documents
S. A. Shalnova, S. A. Maksimov, Yu. A. Balanova, S. E. Evstifeeva, A. E. Imaeva, A. V. Kapustina, G. A. Muromtseva, V. I. Tarasov, I. A. Viktorova, A. N. Redko, N. N. Prishchepa, S. S. Yakushin, O. M. Drapkina
"... (GFR) categories of various levels, as well as associations with a number of cardiovascular diseases ..."
 
Vol 16, No 3 (2020) On the Quality of Medical Examination: Diagnostic Significance of the Survey Method for Detecting the Probability of Cardio-Cerebral Symptoms Abstract  similar documents
A. M. Kalinina, K. A. Antonov, B. E. Gornyi, I. I. Dubovoj, O. M. Drapkina
"... -cerebral symptoms and diseases as an indicator of the quality of its use in the framework of medical ..."
 
Vol 9, No 2 (2013) STATIN SAFETY REVISITED DATA Abstract  similar documents
O. M. Drapkina
"... Questions of statins use in liver diseases are discussed. Data from clinical studies on statins ..."
 
Vol 16, No 5 (2020) Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register Abstract  similar documents
I. S. Skopets, N. N. Vezikova, A. V. Malafeev, A. N. Malygin, V. A. Litvinova
 
Vol 17, No 2 (2021) Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 2: Treatment Options Abstract  similar documents
V. G. Grachev, S. S. Vedenskaya, O. G. Smolenskaya
"... provides a more pronounced decrease in the incidence of cardiovascular complications than in lesions ..."
 
Vol 17, No 1 (2021) Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 1: Risk Stratification and Diagnosis Abstract  similar documents
V. G. Grachev, S. S. Vedenskaya, O. G. Smolenskaya
"... Multifocal arterial disease is common in patients with atherosclerotic cardiovascular disease ..."
 
Vol 15, No 1 (2019) Factors Associated with Cause-Specific Death in Russia. Data from Longitudinal Prospective Study 1977-2001 Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. V. Kapustina, A. D. Deev, Yu. A. Balanova
"... and their associations with cause-specific mortalities: coronary heart disease (CHD), stroke, cardiovascular diseases ..."
 
Vol 15, No 2 (2019) E.I. Chazov and His Role in the Development of the Epidemiology of Cardiovascular Diseases Abstract  similar documents
article Editorial
 
Vol 18, No 1 (2022) Cardioprotective Strategies for Doxorubicin-induced Cardiotoxicity: Present and Future Abstract  similar documents
A. M. Chaulin, D. V. Duplyakov
"... a high risk of developing or are at high risk of death from cardiovascular diseases. One of the main ..."
 
Vol 18, No 2 (2022) Antiarrhythmic and Hemodynamic Effects of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases Abstract  similar documents
A. N. Zakirova, N. E. Zakirova
"... the risk of developing cardiovascular diseases. Experimental studies have shown ω-3 PUFA are exhibiting ..."
 
Vol 10, No 5 (2014) OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... into the outpatient REgistry of CardioVAScular diseAses (RECVASA). 530 of 3690 (14.4%) patients had the diagnosis ..."
 
Vol 9, No 3 (2013) NICOTINE REPLACEMENT THERAPY OF THE TOBACCO ADDICTION IN PREVENTION OF CARDIORESPIRATORY DISEASES Abstract  similar documents
M. G. Gambaryan
"... of cardiorespiratory diseases. Smoking cessation is the most cost-effective measure for prevention of cardiovascular ..."
 
Vol 15, No 5 (2019) The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 1) Abstract  similar documents
A. S. Safaryan, V. S. Sargsyan, T. V. Kamyshova, N. M. Akhmedzhanov, D. V. Nebieridze, E. A. Poddubskaya
"... of the cardiovascular system. These studies show how magnesium deficiency increases the risk of cardiovascular diseases ..."
 
Vol 17, No 4 (2021) Novel Biomarkers of Endothelial Dysfunction in Cardiovascular Diseases Abstract  similar documents
Z. M. Abdurakhmanov, B. Y. Umarov, M. M. Abdurakhmanov
"... and progression of cardiovascular diseases, stratification of their risks, since endothelial dysfunction (ED ..."
 
Vol 12, No 5 (2016) News of the Annual Congress of the European Society of Cardiology in Rome: the Obvious and Proven - it's not the Same Thing Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko
 
Vol 13, No 2 (2017) ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC Abstract  PDF (Eng)  similar documents
E. V. Stepina, M. M. Loukianov, M. A. Bichurina, E. N. Belova, E. V. Kudryashov, Ju. V. Uzkov, S. A. Boytsov
"... (CHF) within the registry of cardiovascular diseases. Material and methods. The study included 285 ..."
 
Vol 13, No 4 (2017) PATIENTS WITH ATRIAL FIBRILLATION IN MULTIDISCIPLINARY HOSPITAL: STRUCTURE OF HOSPITALIZATION, CONCOMITANT CARDIOVASCULAR DISEASES AND DRUG TREATMENT (DATA OF RECVASA AF-TULA REGISTRY) Abstract  similar documents
M. N. Valiakhmetov, T. A. Gomova, M. M. Loukianov, S. Yu. Martsevich, K. N. Nadejkina, M. N. Artemova, D. N. Jilin, E. E. Fedotova, A. V. Zagrebelnyy, E. V. Kudryashov, S. A. Boytsov
"... cardiovascular diseases (CVD) and drug therapy within the RECVAZA AF-Tula hospital registry. Material ..."
 
Vol 14, No 1 (2018) THIRTY-YEAR CHANGES IN AVERAGE BLOOD LIPIDS LEVELS IN POPULATIONS OF THE RUSSIAN FEDERATION AND THE USA Abstract  PDF (Eng)  similar documents
S. A. Shalnova, V. G. Vilkov, V. A. Metelskaya, Yu. A. Balanova, A. V. Kapustina
"... population studies carried out in 1975-1982, the multicenter epidemiological study of cardiovascular diseases ..."
 
Vol 7, No 4 (2011) GENDER DIFFERENCES IN THE EFFICACY OF RISK FACTORS CORRECTION AND TREATMENT COMPLIANCE IN PATIENTS AFTER ACUTE CORONARY SYNDROME Abstract  similar documents
A. Y. Efanov, D. F. Nizamova, E. F. Dorodneva, I. V. Medvedev, S. V. Shalaev
"... Aim. To compare the efficacy of correction of modifiable risk factors for ischemic heart disease ..."
 
1 - 100 of 424 Items 1 2 3 4 5 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)